A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-FORTA 2019)
ConclusionOAC-FORTA 2019 confirms that AFib can be successfully treated with positively labeled antithrombotics at advanced age.
Source: Drugs and Aging - Category: Geriatrics Source Type: research
More News: Atrial Fibrillation | Clinical Trials | Coumadin | Geriatrics | Pradaxa | Study | Vitamin K | Vitamins | Warfarin